Inventor
SELA MICHAEL
IL32 patents
⚠️ This page may combine multiple inventors who share the name “SELA MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YEDA RES & DEV
27 patentsUS7199098B2Apr 3, 2007
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV84 citations99
US6939539B2Sep 6, 2005
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV95 citations99
US6620847B2Sep 16, 2003
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV119 citations99
US6362161B1Mar 26, 2002
Copolymer-1 improvements on compositions of copolymers
YEDA RES & DEV122 citations99
US6342476B1Jan 29, 2002
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV130 citations99
US6054430AApr 25, 2000
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV139 citations99
US6048898AApr 11, 2000
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV134 citations99
US5981589ANov 9, 1999
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV136 citations99
US5800808ASep 1, 1998
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV178 citations99
US7939072B2May 10, 2011
Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same
YEDA RES & DEV46 citations97
US7625861B2Dec 1, 2009
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV24 citations96
US6844314B2Jan 18, 2005
Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
YEDA RES & DEV95 citations96
US6214791B1Apr 10, 2001
Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
YEDA RES & DEV125 citations95
US6217866B1Apr 17, 2001
Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
YEDA RES & DEV310 citations93
US8367605B2Feb 5, 2013
Copolymer-1 improvements in compositions of copolymers
YEDA RES & DEV14 citations92
US7498142B2Mar 3, 2009
Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
YEDA RES & DEV31 citations92
US7425332B2Sep 16, 2008
Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
YEDA RES & DEV41 citations92
US5858964AJan 12, 1999
Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
YEDA RES & DEV62 citations92
US7407936B2Aug 5, 2008
Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
YEDA RES & DEV27 citations91
US4263279AApr 21, 1981
Pharmaceutically active compositions containing adriamycin and daunomycin
YEDA RES & DEV41 citations90
US4093607AJun 6, 1978
Immunologic chemotherapeutic agents comprising antigen binding dimers covalently bound to drugs
YEDA RES & DEV41 citations90
US7053043B1May 30, 2006
Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD
YEDA RES & DEV16 citations83
US6066621AMay 23, 2000
Synthetic peptides for the treatment of myasthenia gravis
YEDA RES & DEV9 citations72
US4751064AJun 14, 1988
Synthetic chollera vaccine
YEDA RES & DEV10 citations72
US4075194AFeb 21, 1978
Novel synthetic undecapeptide and clinical assay
YEDA RES & DEV12 citations69
US9358288B2Jun 7, 2016
Antibody combinations and use of same for treating cancer
YEDA RES & DEV0 citations47
US9926564B2Mar 27, 2018
Aptamers, multimeric aptamers and uses thereof
YEDA RES & DEV0 citations46